UniProt ID | IL7RA_HUMAN | |
---|---|---|
UniProt AC | P16871 | |
Protein Name | Interleukin-7 receptor subunit alpha | |
Gene Name | IL7R | |
Organism | Homo sapiens (Human). | |
Sequence Length | 459 | |
Subcellular Localization |
Isoform 1: Cell membrane Single-pass type I membrane protein. Isoform 3: Cell membrane Single-pass type I membrane protein. Isoform 4: Secreted. |
|
Protein Description | Receptor for interleukin-7. Also acts as a receptor for thymic stromal lymphopoietin (TSLP).. | |
Protein Sequence | MTILGTTFGMVFSLLQVVSGESGYAQNGDLEDAELDDYSFSCYSQLEVNGSQHSLTCAFEDPDVNTTNLEFEICGALVEVKCLNFRKLQEIYFIETKKFLLIGKSNICVKVGEKSLTCKKIDLTTIVKPEAPFDLSVIYREGANDFVVTFNTSHLQKKYVKVLMHDVAYRQEKDENKWTHVNLSSTKLTLLQRKLQPAAMYEIKVRSIPDHYFKGFWSEWSPSYYFRTPEINNSSGEMDPILLTISILSFFSVALLVILACVLWKKRIKPIVWPSLPDHKKTLEHLCKKPRKNLNVSFNPESFLDCQIHRVDDIQARDEVEGFLQDTFPQQLEESEKQRLGGDVQSPNCPSEDVVITPESFGRDSSLTCLAGNVSACDAPILSSSRSLDCRESGKNGPHVYQDLLLSLGTTNSTLPPPFSLQSGILTLNPVAQGQPILTSLGSNQEEAYVTMSSFYQNQ | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
49 | N-linked_Glycosylation | CYSQLEVNGSQHSLT EEEEEEECCCEEEEE | 34.72 | 19141282 | |
65 | N-linked_Glycosylation | AFEDPDVNTTNLEFE EEECCCCCCCCEEEE | 48.87 | 19141282 | |
96 | Phosphorylation | QEIYFIETKKFLLIG EEEEEEEECEEEEEC | 34.42 | 26074081 | |
151 | N-linked_Glycosylation | NDFVVTFNTSHLQKK CCEEEEEEHHHHHHH | 31.16 | 19141282 | |
159 | Phosphorylation | TSHLQKKYVKVLMHD HHHHHHHHHHHHHHH | 16.73 | 26074081 | |
169 | Phosphorylation | VLMHDVAYRQEKDEN HHHHHHHHHCCCCCC | 16.81 | 26074081 | |
182 | N-linked_Glycosylation | ENKWTHVNLSSTKLT CCCCEEEECCHHHHH | 26.97 | UniProtKB CARBOHYD | |
189 | Phosphorylation | NLSSTKLTLLQRKLQ ECCHHHHHHHHHHHC | 27.29 | 23612710 | |
232 | N-linked_Glycosylation | YFRTPEINNSSGEMD EECCCCCCCCCCCCC | 40.44 | UniProtKB CARBOHYD | |
233 | N-linked_Glycosylation | FRTPEINNSSGEMDP ECCCCCCCCCCCCCH | 43.12 | UniProtKB CARBOHYD | |
282 | Phosphorylation | SLPDHKKTLEHLCKK CCCCHHHHHHHHCCC | 42.03 | - | |
292 | Ubiquitination | HLCKKPRKNLNVSFN HHCCCCCCCCCCCCC | 74.45 | - | |
297 | Phosphorylation | PRKNLNVSFNPESFL CCCCCCCCCCHHHHH | 20.45 | 25159151 | |
337 | Ubiquitination | QQLEESEKQRLGGDV HHHHHHHHHHCCCCC | 50.42 | 21987572 | |
346 | Phosphorylation | RLGGDVQSPNCPSED HCCCCCCCCCCCCCC | 20.23 | 25159151 | |
365 | Phosphorylation | PESFGRDSSLTCLAG CHHHCCCCCCEEECC | 26.36 | 26657352 | |
366 | Phosphorylation | ESFGRDSSLTCLAGN HHHCCCCCCEEECCC | 31.80 | 24114839 | |
368 | Phosphorylation | FGRDSSLTCLAGNVS HCCCCCCEEECCCCC | 13.86 | 26657352 | |
375 | Phosphorylation | TCLAGNVSACDAPIL EEECCCCCCCCCCCC | 27.46 | 21712546 | |
449 | Phosphorylation | GSNQEEAYVTMSSFY CCCCCEEEEEHHHHH | 10.34 | 22817900 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
282 | T | Phosphorylation | Kinase | PKC | - | Uniprot |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of IL7RA_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
346 | Phosphorylation | 356 (10) | I ⇒ V | rs3194051 |
| 21297633 |
365 | Phosphorylation | 356 (9) | I ⇒ V | rs3194051 |
| 21297633 |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
FYN_HUMAN | FYN | physical | 7515933 | |
KIT_HUMAN | KIT | physical | 17554063 | |
JAK3_HUMAN | JAK3 | physical | 17554063 | |
CISH_HUMAN | CISH | physical | 27596538 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
H00091 | T-B+Severe combined immunodeficiencies (SCIDs), including the following eight diseases: X-linked SCI | |||||
OMIM Disease | ||||||
608971 | Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-positive/NK-cell-positive (T(-)B(+)NK(+) SCID) | |||||
612595 | Multiple sclerosis 3 (MS3) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
N-linked Glycosylation | |
Reference | PubMed |
"Structural and biophysical studies of the human IL-7/IL-7Ralphacomplex."; McElroy C.A., Dohm J.A., Walsh S.T.; Structure 17:54-65(2009). Cited for: X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF 21-239 IN COMPLEX WITH IL7,SUBUNIT, GLYCOSYLATION AT ASN-49; ASN-65 AND ASN-151, AND DISULFIDEBONDS. | |
Phosphorylation | |
Reference | PubMed |
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."; Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.; J. Proteome Res. 6:4150-4162(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-159 AND TYR-169, ANDMASS SPECTROMETRY. |